Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$286.58K

Rothblatt Martine A Chairperson & CEO

Transaction date Oct 16, 2026
Public filing date Oct 19, 2026
Filing lag Filed 3 days later

UTHR daily price context

Close on/before transaction
$533.12 Oct 16, 2026
First close after public filing
$553.88 Oct 20, 2026
Return after filing · so far
+7.54% Through Nov 11, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
535 shares @ $535.67
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000166
Filing cohort

Transactions in this filing

Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$6.2M
Buys / sales
0 / 13
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Oct 16, 2026 $342.02K
United Therapeutics Corp UTHR Exercise Oct 16, 2026 $0
United Therapeutics Corp UTHR Current Sale Oct 16, 2026 $286.58K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $408.68K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $215.96K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $91.53K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $464.21K
United Therapeutics Corp UTHR Exercise Oct 16, 2026 $1.12M
United Therapeutics Corp UTHR Sale Oct 16, 2026 $127.31K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $544.3K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $1.27M
United Therapeutics Corp UTHR Sale Oct 16, 2026 $969.58K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $212.19K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $21.75K
United Therapeutics Corp UTHR Sale Oct 16, 2026 $128.96K